|
End-of-day quote
Johannesburg S.E.
2026-08-17
|
5-day change | 1st Jan Change | ||
| 141.94 ZAR | -1.21% |
|
-6.75% | +21.53% |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic injection | RE |
| Market Cap | 63.02B 3.9B 3.37B 3.16B 2.88B 5.41B 373B 5.48B 37.02B 14.51B 187B 14.64B 14.32B 621B | P/E 2026 * |
14.4x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 75.9B 4.7B 4.05B 3.8B 3.46B 6.51B 449B 6.6B 44.58B 17.47B 225B 17.63B 17.25B 748B | EV / Sales 2026 * |
2.02x | EV / Sales 2027 * | 1.58x |
| Free-Float |
59.64% | Yield 2026 * |
1.87% | Yield 2027 * | 1.77% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | -1.21% | ||
| 1 week | -6.75% | ||
| Current month | -4.80% | ||
| 1 month | -5.57% | ||
| 3 months | +1.06% | ||
| 6 months | +14.47% | ||
| Current year | +21.53% |
| 1 week | 140.5 |  | 149.04 |
| 1 month | 140.5 | | 158.55 |
| Current year | 104.38 | | 160.79 |
| 1 year | 90.7 | | 160.79 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 372.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 1998-12-31 | |
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | -6.75% | +26.22% | -26.64% | 3.9B | |
| -0.37% | -3.44% | +14.85% | +65.22% | 47.23B | |
| +0.21% | -1.71% | +51.94% | +122.92% | 39.62B | |
| -0.03% | -2.18% | -8.57% | +15.75% | 12.09B | |
| -1.41% | -6.33% | +13.09% | +72.20% | 11.8B | |
| +0.58% | 0.00% | +30.65% | +148.80% | 9.12B | |
| -1.15% | -1.46% | +21.57% | +39.22% | 7.57B | |
| +1.33% | +1.01% | +44.58% | -11.96% | 7.1B | |
| -1.03% | +1.27% | +16.77% | +200.84% | 6.87B | |
| +0.63% | -2.55% | -30.10% | +23.92% | 5.81B | |
| Average | -0.25% | -0.89% | +18.10% | +65.03% | 15.11B | |
| Weighted average by Cap. | -0.19% | -2.17% | +23.90% | +79.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.33B 2.01B 1.88B 1.72B 3.23B 223B 3.27B 22.09B 8.66B 111B 8.74B 8.55B 371B | 38.86B 2.4B 2.08B 1.95B 1.77B 3.33B 230B 3.38B 22.82B 8.94B 115B 9.03B 8.83B 383B |
| Net income | 4.8B 297M 256M 240M 219M 412M 28.38B 417M 2.82B 1.1B 14.22B 1.11B 1.09B 47.29B | 5B 309M 267M 250M 228M 429M 29.55B 435M 2.93B 1.15B 14.8B 1.16B 1.14B 49.24B |
| Net Debt | 12.88B 797M 688M 645M 588M 1.1B 76.17B 1.12B 7.56B 2.96B 38.16B 2.99B 2.93B 127B | -1.74B -107M -92.67M -86.94M -79.18M -149M -10.26B -151M -1.02B -399M -5.14B -403M -394M -17.1B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | ZAR 141.94 | -1.21% | 969,449 |
| 26-08-14 | ZAR 143.68 | +0.24% | 1,674,274 |
| 26-08-13 | ZAR 143.33 | -1.39% | 2,304,506 |
| 26-08-12 | ZAR 145.35 | -1.00% | 2,344,824 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
